Cost considerations Pharmaceutical semaglutide (Wegovy): $1,300-1,500/month without insurance Insurance may cover (varies) Patient assistance programs available Research semaglutide: $150-300/month No insurance No patient assistance User assumes risk Research cagrilintide: $200-400/month Not prescription available yet Higher cost due to limited availability Total CagriSema combination cost (research chemicals): $350-700/month Both peptides at full dose Significant investment Compare to bariatric surgery ($15,000-25,000 upfront) Budget planning: Year 1 (titration + maintenance): $4,200-8,400 Ongoing maintenance: $350-700/month Consider reducing to maintenance doses May need 12-24+ months total Use our peptide cost calculator to budget protocols
Studies examining multi-dose vial sterility have documented that preservative-containing diluents maintain vial integrity through the labeled use period (PMID: 6562087)
HPLC Tested / 99% purity / Pan-India delivery / Cash on Delivery available Research Use Only This product is intended solely for laboratory and research purposes
The aortas were then incubated in freshly prepared SA--Gal staining solution at pH 6.0 overnight at 37 C, according to the manufacturers protocol
Product Specifications CAS Number : 221231103 Peptide Sequence : TyrLeuArgIleValGlnCysArgSerValGluGlySerCysGlyPheOH Molecular Weight : 1815.10 g/mol Chemical Formula : CHNOS Purity : 99% (HPLC) Packaging Format : 5 mg lyophilized powder in a researchgrade glass vial Storage Conditions (unreconstituted) : Store at 20 C, avoid light exposure
